[1] Beaufrère A, Caruso S, Calderaro J, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol,2022,76(2):343-352. [2] Liu B, Zeng Q, Huang J, et al. IVIM using convolutional neural networks predicts microvascular invasion in HCC. Eur Radiol,2022,32(10):7185-7195. [3] Wu DJ, Rao SX, Yang C, et al. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm. Eur Radiol,2021,31(7):4824-4838. [4] Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol,2019,26(5):1474-1493. [5] Li Y, Zhang Y, Fang Q, et al. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging,2021,48(8):2599-2614. [6] Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan Criteria. JAMA Surg,2016,151(4):356-63. [7] Mayerhoefer ME, Materka A, Langs G, et al. Introduction to Radiomics. J Nucl Med,2020,61(4):488-495. [8] Coates JTT, Pirovano G, El Naqa I. Radiomic and radiogenomic modeling for radiotherapy: strategies, pitfalls, and challenges. J Med Imaging (Bellingham),2021,8(3):031902. [9] Davey MG, Davey MS, Boland MR, et al. Radiomic differentiation of breast cancer molecular subtypes using pre-operative breast imaging-a systematic review and meta-analysis. Eur J Radiol,2021,144:109996. [10] Llovet JM, Villanueva A, Marrero JA, et al. Trial design and endpoints in hepatocellular carcinoma: AASLD consensus conference. Hepatology,2021,73 Suppl 1:158-191. |